MASI, GIANLUCA
 Distribuzione geografica
Continente #
EU - Europa 28
AS - Asia 26
NA - Nord America 19
Totale 73
Nazione #
US - Stati Uniti d'America 19
HK - Hong Kong 12
IE - Irlanda 11
IT - Italia 8
JO - Giordania 6
CN - Cina 5
SE - Svezia 3
SG - Singapore 2
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
GB - Regno Unito 1
ID - Indonesia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 73
Città #
Hong Kong 12
Dublin 11
Shanghai 4
Ashburn 3
Bari 2
Chandler 2
Rieti 2
Rome 2
Singapore 2
West Jordan 2
Acton 1
Amsterdam 1
Beijing 1
Brno 1
Helsinki 1
Kent 1
Moscow 1
Naples 1
Paris 1
Seattle 1
Surabaya 1
Totale 53
Nome #
TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer 32
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 25
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 21
Totale 78
Categoria #
all - tutte 688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 688


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202334 0 0 0 3 2 7 8 4 7 1 0 2
2023/202442 4 5 2 4 1 3 3 13 0 3 2 2
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 78